Public Profile

Cansino Biologics

Cansino Biologics Inc., commonly referred to as Cansino, is a prominent biopharmaceutical company headquartered in China (CN). Founded in 2009, the company has established itself as a leader in the development of innovative vaccines and biologics, with a strong focus on addressing global health challenges. Cansino operates primarily in the fields of vaccine research and development, particularly in the areas of infectious diseases and oncology. The company gained significant recognition for its pioneering work on the Ad5-nCoV vaccine, which was one of the first COVID-19 vaccines to receive emergency use authorisation. Cansino's unique adenoviral vector platform sets it apart in the industry, enabling rapid development and deployment of vaccines. With a robust pipeline and strategic partnerships, Cansino Biologics continues to solidify its position as a key player in the global biopharmaceutical landscape.

DitchCarbon Score

How does Cansino Biologics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

32

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

24

Industry Benchmark

Cansino Biologics's score of 32 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.

91%

Cansino Biologics's reported carbon emissions

In 2023, Cansino Biologics reported total carbon emissions of approximately 37,294,900 kg CO2e, comprising 2,335,900 kg CO2e from Scope 1 and 19,689,150 kg CO2e from Scope 2 emissions. The company has shown a significant reduction in emissions compared to previous years, particularly from 2021, where total emissions were about 35,159,360 kg CO2e. Cansino Biologics has disclosed emissions data for Scope 1 and Scope 2, but there is no available data for Scope 3 emissions. The company has not set specific reduction targets or initiatives as part of its climate commitments, indicating a potential area for future development in their sustainability strategy. Overall, Cansino Biologics is actively monitoring its carbon footprint, with a focus on reducing emissions from its operations, but further commitments and targets could enhance its climate action efforts.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20192020202120222023
Scope 1
4,609,750
00,000,000
00,000,000
00,000,000
0,000,000
Scope 2
10,386,950
000
00,000,000
00,000,000
00,000,000
Scope 3
-
0,000
000
00,000,000
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Cansino Biologics's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Cansino Biologics is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Cansino Biologics is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Similar Organizations

Serum Institute of India Pvt. Ltd.

IN
Health and social work services (85)
Updated about 1 month ago

Beijing Institute of Biological Products Co., Ltd

CN
Health and social work services (85)
Updated about 2 months ago
DitchCarbon Score

Bharat Biotech Ltd.

IN
Health and social work services (85)
Updated 13 days ago

VBI Vaccines Inc.

US
Health and social work services (85)
Updated 24 days ago

AstraZeneca AB

SE
Chemicals nec
Updated about 2 months ago
DitchCarbon Score

Sinovac Life Sciences Co., Ltd.

CN
Updated about 2 months ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers